231 related articles for article (PubMed ID: 28084627)
1. Carvacrol after status epilepticus (SE) prevents recurrent SE, early seizures, cell death, and cognitive decline.
Khalil A; Kovac S; Morris G; Walker MC
Epilepsia; 2017 Feb; 58(2):263-273. PubMed ID: 28084627
[TBL] [Abstract][Full Text] [Related]
2. TRPM7 inhibitor carvacrol protects brain from neonatal hypoxic-ischemic injury.
Chen W; Xu B; Xiao A; Liu L; Fang X; Liu R; Turlova E; Barszczyk A; Zhong X; Sun CL; Britto LR; Feng ZP; Sun HS
Mol Brain; 2015 Feb; 8():11. PubMed ID: 25761704
[TBL] [Abstract][Full Text] [Related]
3. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
[TBL] [Abstract][Full Text] [Related]
4. Effect of levetiracetam on visual-spatial memory following status epilepticus.
Zhou JL; Zhao Q; Holmes GL
Epilepsy Res; 2007 Jan; 73(1):65-74. PubMed ID: 17029741
[TBL] [Abstract][Full Text] [Related]
5. Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model.
Licko T; Seeger N; Zellinger C; Russmann V; Matagne A; Potschka H
Epilepsia; 2013 Jul; 54(7):1176-85. PubMed ID: 23614482
[TBL] [Abstract][Full Text] [Related]
6. Glibenclamide ameliorates cerebral edema and improves outcomes in a rat model of status epilepticus.
Lin Z; Huang H; Gu Y; Huang K; Hu Y; Ji Z; Wu Y; Wang S; Yang T; Pan S
Neuropharmacology; 2017 Jul; 121():1-11. PubMed ID: 28412320
[TBL] [Abstract][Full Text] [Related]
7. Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons.
Gorter JA; van Vliet EA; Aronica E; Lopes da Silva FH
Eur J Neurosci; 2001 Feb; 13(4):657-69. PubMed ID: 11207801
[TBL] [Abstract][Full Text] [Related]
8. Synergism between topiramate and budipine in refractory status epilepticus in the rat.
Fisher A; Wang X; Cock HR; Thom M; Patsalos PN; Walker MC
Epilepsia; 2004 Nov; 45(11):1300-7. PubMed ID: 15509230
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of remacemide hydrochloride in a perforant pathway stimulation model of status epilepticus in the rat.
Halonen T; Nissinen J; Pitkänen A
Epilepsy Res; 1999 Apr; 34(2-3):251-69. PubMed ID: 10210040
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.
Brandt C; Glien M; Gastens AM; Fedrowitz M; Bethmann K; Volk HA; Potschka H; Löscher W
Neuropharmacology; 2007 Aug; 53(2):207-21. PubMed ID: 17585956
[TBL] [Abstract][Full Text] [Related]
11. Chronic elevation of brain GABA levels beginning two days after status epilepticus does not prevent epileptogenesis in rats.
Halonen T; Nissinen J; Pitkänen A
Neuropharmacology; 2001 Mar; 40(4):536-50. PubMed ID: 11249963
[TBL] [Abstract][Full Text] [Related]
12. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
Gibbs JE; Walker MC; Cock HR
Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608
[TBL] [Abstract][Full Text] [Related]
13. Long-term neuronal replacement in adult rat hippocampus after status epilepticus despite chronic inflammation.
Bonde S; Ekdahl CT; Lindvall O
Eur J Neurosci; 2006 Feb; 23(4):965-74. PubMed ID: 16519661
[TBL] [Abstract][Full Text] [Related]
14. The erythropoietin-derived peptide mimetic pHBSP affects cellular and cognitive consequences in a rat post-status epilepticus model.
Seeger N; Zellinger C; Rode A; Roloff F; Bicker G; Russmann V; Fischborn S; Wendt H; Potschka H
Epilepsia; 2011 Dec; 52(12):2333-43. PubMed ID: 22050420
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective properties of topiramate in the lithium-pilocarpine model of epilepsy.
Rigoulot MA; Koning E; Ferrandon A; Nehlig A
J Pharmacol Exp Ther; 2004 Feb; 308(2):787-95. PubMed ID: 14593082
[TBL] [Abstract][Full Text] [Related]
16. Diabetic hyperglycemia aggravates seizures and status epilepticus-induced hippocampal damage.
Huang CW; Cheng JT; Tsai JJ; Wu SN; Huang CC
Neurotox Res; 2009 Jan; 15(1):71-81. PubMed ID: 19384590
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
Langer M; Brandt C; Zellinger C; Löscher W
Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
[TBL] [Abstract][Full Text] [Related]
18. Effects of rapamycin and curcumin treatment on the development of epilepsy after electrically induced status epilepticus in rats.
Drion CM; Borm LE; Kooijman L; Aronica E; Wadman WJ; Hartog AF; van Vliet EA; Gorter JA
Epilepsia; 2016 May; 57(5):688-97. PubMed ID: 26924447
[TBL] [Abstract][Full Text] [Related]
19. Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia.
Sun HS; Jackson MF; Martin LJ; Jansen K; Teves L; Cui H; Kiyonaka S; Mori Y; Jones M; Forder JP; Golde TE; Orser BA; Macdonald JF; Tymianski M
Nat Neurosci; 2009 Oct; 12(10):1300-7. PubMed ID: 19734892
[TBL] [Abstract][Full Text] [Related]
20. Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus.
Halonen T; Nissinen J; Jansen JA; Pitkänen A
Eur J Pharmacol; 1996 Mar; 299(1-3):69-81. PubMed ID: 8901009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
